ArticleAdvances in therapy2026

Comparative Effectiveness and Risk of Severe Infection in Adult Patients With MS Treated With Diroximel Fumarate Versus Anti-CD20 Monoclonal Antibodies: A Real-World Claims Analysis.

Ahmed Z Obeidat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.